临床药师处方审核对静脉配置中心抗肿瘤药物不合理医嘱干预效果分析

Abstract
Figure/Table
References (16)
Related Citation (11)

Download: PDF (0 KB) HTML (28 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the intervention effect of clinical pharmacist reviewing on the unreasonable medical prescriptions of anti-tumor drugs in the vein configuration center. Methods The clinical drug system and hospital information system (HIS) were retrospectively analyzed. The anti-tumor drugs for inpatients in our hospital from January to June in 2018 were used to calculate the irrational use of drugs, as data before intervention. From July to December in 2018, clinical pharmacists participated in the medical reviewing, intervened when there were unreasonable medical prescriptions, and recorded the irrational use of drugs as data after intervention. The data obtained in the hospital throughout the year were statistically analyzed to compare the unreasonable medical prescriptions change of anti-tumor drugs before and after intervention and the effect of pharmacist intervention. Results The unreasonable rate of medical prescription after intervention was 3.28%, which was lower than 8.78% before intervention, with statistically significant difference (P＜0.05). There were statistically significant differences in the unreasonable rates of medical prescriptions of gynecology, otolaryngology, oncology, hepatobiliary gastrointestinal surgery, and thoracic surgery departments before and after intervention (P＜0.05). There were no significant differences in the unreasonable rates of medical prescriptions of radiotherapy and other departments before and after intervention (P＞0.05). Conclusion There are varied degrees of unreasonable medical prescriptions in different departments. Intervention by clinical pharmacists can effectively reduce the incidence of unreasonable anti-tumor drugs and avoid or reduce the incidence of adverse drug reactions.

Key words： Anti-tumor drugs Unreasonable medical prescription Clinical pharmacists Intervention effect Medical prescription review

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEN Jian-kun
	HUANG Xiang-zhen
	ZHEN Ju-quan

Cite this article:

WEN Jian-kun,HUANG Xiang-zhen,ZHEN Ju-quan. Intervention effect analysis of clinical pharmacist reviewing on the unreasonable medical prescriptions of anti-tumor drugs in the vein configuration center[J]. 中国当代医药, 2020, 27(7): 175-177.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I7/175

[1]	贾东丽，王天珩，井慧超.临床药师参与胸外科化疗患者医嘱审核干预效果分析[J].中国医药导刊，2018，20（6）：341-345.
[2]	纪立伟，赵紫楠，姜微哲，等.临床药师对内分泌科住院医嘱的干预及效果评价[J].中国药物应用与监测，2017，14（3）：183-186.
[3]	陈集志，李刚，李忠东，等.临床药师对96 例肾功能重度不全患者医嘱的优化干预效果分析[J].中国药物应用与监测，2016，13（4）：247-250.
[4]	舒扬，杨怡，高天行，等.探索基于临床药师信息管理系统的病区用药医嘱审核模式[J].药学服务与研究，2017，17（1）：54-57.
[5]	Weddle SC，Rowe AS，Jeter JW，et al.Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly[J].J Manag Care Spec Pharm，2017，23（5）：520-524.
[6]	方维军，张艳丽，袁曼.临床药师对临床不合理用药事先干预模式的探索[J].安徽医药，2016，20（11）：2173-2176.
[7]	杨智，彭翠英，张海霞，等.我院住院医嘱1236 例不合理用药分析[J].儿科药学杂志，2016，22（1）：41-43.
[8]	Ottman AA，Townsend ML，Hashem MG，et al.Incidence of drug interactions identified by clinical pharmacists in Veterans initiating treatment for chronic hepatitis C infection[J].Ann Pharmacother，2018，52（8）：763-768.
[9]	姚慧娟，李平，刘昕竹，等.临床药师开展内科住院患者入院药物重整的药学服务实践[J].中国药房，2017，28（32）：4580-4584.
[10]	苏芬丽，姚媛，利亭婷，等.内分泌科临床药师对住院医嘱的干预记录分析[J].中国药师，2018，21（4）：681-684.
[11]	晋亚楠，夏爱军，梁园，等.某院抗肿瘤药物医嘱审核情况分析及临床干预[J].广西医学，2015，4（2）：262-264.
[12]	王书杰，王丽萍，李小云.临床药师参与医嘱审核工作的体会[J].解放军药学学报，2016，32（1）：98-99.
[13]	Abdel Shaheed C，Graves J，Maher C.The effects of a brief educational intervention on medical students′ knowledge，attitudes and beliefs towards low back pain[J].Scand J Pain，2017，16（2）：101-104.
[14]	张在丽，崔敏.临床药师在医嘱安全管理中的工作探讨[J].中国药师，2016，19（4）：703-706.
[15]	陈杨，吕娟，徐云云，等.我院结肠癌抗肿瘤治疗药物合理应用点评分析[J].中南药学，2017，15（11）：1643-1646.
[16]	蔡红，陈红红，邓伦平.静脉药物配置不合理及干预分析[J].当代医学，2019，25（20）：66-68.